Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's Disease

GSK2330811 will be available as SC injection with a unit dose strength of 150 mg/mL. GSK2330811 will be available in single-use pre-filled syringe.

Placebo will be available as SC injection of 0.9 percent saline solution. It will be available as single-use pre-filled syringe.